Champions Oncology Inc.
CSBR | NASDAQ
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2026 Apr 30, 2026 | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 | FY 2021 Apr 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 59.43M | 56.94M | 50.16M | 53.87M | 49.11M | 41.04M |
Cost of Revenue | 30.9M | 28.39M | 29.4M | 29.53M | 23.63M | 21.45M |
Gross Profit | 28.53M | 28.56M | 20.75M | 24.34M | 25.48M | 19.59M |
Operating Income | -1.14M | 4.85M | -6.92M | -4.45M | 607K | 366K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -929K | 4.63M | -7.31M | -5.27M | 583K | 437K |
Net Income | -1.18M | 4.7M | -7.28M | -5.34M | 548K | 362K |
Selling & General & Admin | 20.47M | 16.88M | 18.13M | 17.24M | 15.5M | 12.03M |
Research & Development | 9.08M | 6.83M | 9.54M | 11.55M | 9.37M | 7.2M |
Other Expenses | 111K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.67M | 23.71M | 27.68M | 28.79M | 24.87M | 19.23M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 9.32M | 7.55M | 7.06M | 7M | 6.38M | 5.52M |
Cost & Expenses | 60.57M | 52.1M | 57.08M | 58.32M | 48.5M | 40.67M |
Income Tax Expense | 246K | -75K | -32K | 68K | 35K | 75K |
Shares Outstanding (Basic) | 13.83M | 13.66M | 13.55M | 13.54M | 13.2M | 13.14M |
Shares Outstanding (Diluted) | 13.83M | 14.27M | 13.55M | 13.54M | 14.16M | 14.57M |
EPS (Basic) | -0.08 | 0.34 | -0.54 | -0.39 | 0.04 | 0.03 |
EPS (Diluted) | -0.08 | 0.33 | -0.54 | -0.39 | 0.04 | 0.02 |
EBITDA | 448K | 6.27M | -5.44M | -3.02M | 2.21M | 1.55M |
EBIT | -929K | 4.63M | -7.31M | -5.27M | 583K | 366K |
Depreciation & Amortization | 1.38M | 1.64M | 1.87M | 2.25M | 1.63M | 1.18M |
Add to Watchlist
Select watchlists to add or remove CSBR